Evaluating the Efficacy and Safety of Remimazolam Tosilate for Injection for Prolonged Mechanical Ventilation Sedation in the Intensive Care Unit (ICU) - A Non-randomized, Multicenter, Single-arm, Open-label, Proof-of-concept, Phase I/II Clinical Trial
Latest Information Update: 30 Jun 2023
At a glance
- Drugs Remimazolam (Primary)
- Indications Sedation
- Focus Proof of concept; Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 27 Jun 2023 Status changed from not yet recruiting to recruiting.
- 26 Jun 2023 New trial record